Advertisement
U.S. markets closed

Kingworld Medicines Group Limited (1110.HK)

HKSE - HKSE Delayed Price. Currency in HKD
0.590-0.010 (-1.67%)
As of 04:08PM HKT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
Market Cap (intraday)
373.50M
Enterprise Value
408.36M
Trailing P/E
8.88
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
0.31
Price/Book (mrq)
0.51
Enterprise Value/Revenue
0.37
Enterprise Value/EBITDA
3.96

Trading Information

Stock Price History

Beta (5Y Monthly) 0.73
52-Week Change 33.51%
S&P500 52-Week Change 328.64%
52 Week High 30.920
52 Week Low 30.485
50-Day Moving Average 30.582
200-Day Moving Average 30.655

Share Statistics

Avg Vol (3 month) 3298.85k
Avg Vol (10 day) 337.2k
Shares Outstanding 5622.5M
Implied Shares Outstanding 6632.88M
Float 8154.11M
% Held by Insiders 166.37%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.02
Forward Annual Dividend Yield 44.12%
Trailing Annual Dividend Rate 30.02
Trailing Annual Dividend Yield 33.67%
5 Year Average Dividend Yield 42.96
Payout Ratio 436.36%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 01, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 3.32%
Operating Margin (ttm)10.47%

Management Effectiveness

Return on Assets (ttm)4.74%
Return on Equity (ttm)7.42%

Income Statement

Revenue (ttm)1.09B
Revenue Per Share (ttm)1.82
Quarterly Revenue Growth (yoy)31.80%
Gross Profit (ttm)N/A
EBITDA 121.29M
Net Income Avi to Common (ttm)36.26M
Diluted EPS (ttm)0.070
Quarterly Earnings Growth (yoy)55.80%

Balance Sheet

Total Cash (mrq)271.06M
Total Cash Per Share (mrq)0.44
Total Debt (mrq)302.74M
Total Debt/Equity (mrq)39.94%
Current Ratio (mrq)1.10
Book Value Per Share (mrq)1.08

Cash Flow Statement

Operating Cash Flow (ttm)176.92M
Levered Free Cash Flow (ttm)19.33M